Use of fractional dose-volume histograms to model risk of acute rectal toxicity among patients treated on RTOG 94-06

Radiotherapy and Oncology

Volumn 104, Issue 1, 2012, Pages 109-113

  Tucker, Susan L ^a   Michalski, Jeff M ^b   Bosch, Walter R ^b   Mohan, Radhe ^a   Dong, Lei ^a   Winter, Kathryn ^c   Purdy, James A ^d   Cox, James D ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b WASHINGTON UNIVERSITY   (United States)

^c American College of Radiology   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Acute rectal toxicity; Dose volume histogram; Lyman model; Normal tissue complication probability; Prostate cancer

Indexed keywords

ADJUVANT CHEMOTHERAPY; ADULT; AGED; CANCER HORMONE THERAPY; CLINICAL PROTOCOL; COMPUTER ASSISTED RADIOTHERAPY; HISTOGRAM; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RECTUM DISEASE; REVIEW; RISK; STATISTICAL MODEL;

EID: 84863216270     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2012.04.023     Document Type: Article

References (20)

1. J.M. Michalski, H. Gay, A. Jackson, S.L. Tucker, and J.O. Deasy Radiation dose-volume effects in radiation-induced rectal injury Int J Radiat Oncol Biol Phys 3 2010 S123 S129
2. J.C. Cheng, T.E. Schultheiss, K.H. Nguyen, and J.Y.C. Wong Acute toxicity in definitive versus postprostatectomy image-guided radiotherapy for prostate cancer Int J Radiat Oncol Biol Phys 71 2008 351 357
3. B.A. Jereczek-Fossa, D. Zerini, and C. Fodor Correlation between acute and late toxicity in 973 prostate cancer patients treated with three-dimensional conformal external beam radiotherapy Int J Radiat Oncol Biol Phys 78 2010 26 34
4. A. Karlsdottir, D.C. Johannessen, L.P. Muren, T. Wentzel-Larsen, and O. Dahl Acute morbidity related to treatment volume during 3D-conformal radiation therapy for prostate cancer Radiother Oncol 71 2004 43 53 (Pubitemid 38452901)
5. F. Leborgne, and J. Fowler Acute toxicity after hypofractionated conformal radiotherapy for localized prostate cancer: nonrandomized contemporary comparison with standard fractionation Int J Radiat Oncol Biol Phys 72 2008 770 776
6. J.J. Nuyttens, S. Milito, P.F. Rust, and A.T. Turrisi Dose-volume relationship for acute side effects during high dose conformal radiotherapy for prostate cancer Radiother Oncol 64 2002 209 214 (Pubitemid 35247900)
7. S.T.H. Peeters, W.D. Heemsbergen, and W.L.J. Putten Acute and late complications after radiotherapy for prostate cancer: results of a multicenter randomized trial comparing 68 Gy to 78 Gy Int J Radiat Oncol Biol Phys 61 2006 1019 1034
8. S.T.H. Peeters, M.S. Hoogeman, and W.D. Heemsbergen Volume and hormonal effects for acute side effects of rectum and bladder during conformal radiotherapy for prostate cancer Int J Radiat Oncol Biol Phys 63 2005 1142 1152 (Pubitemid 41505294)
9. L. Strigari, G. Arcangeli, S. Arcangeli, and M. Benassi Mathematical model for evaluating incidence of acute rectal toxicity during conventional or hypofractionated radiotherapy courses for prostate cancer Int J Radiat Oncol Biol Phys 73 2009 1454 1460
10. B.S. Teh, W.Y. Mai, and B.M. Uhl Intensity-modulated radiation therapy (IMRT) for prostate cancer with the use of a rectal balloon for prostate immobilization: acute toxicity and dose-volume analysis Int J Radiat Oncol Biol Phys 49 2001 705 712 (Pubitemid 32114105)
11. R. Valdagni, A. Magli, and M. Baccolini Development of a set of nomograms to predict acute lower gastrointestinal toxicity for prostate cancer 3D-CRT Int J Radiat Oncol Biol Phys 71 2008 1065 1073
12. V. Vavassori, C. Fiorino, and T. Rancati Predictors for rectal and intestinal acute toxicities during prostate cancer high-dose 3D-CRT: results of a prospective multicenter study Int J Radiat Oncol Biol Phys 67 2007 1401 1410 (Pubitemid 46467147)
13. J.M. Michalski, K. Bae, and M. Roach Long-term toxicity following 3D conformal radiation therapy for prostate cancer from the RTOG 9406 phase I/II dose escalation study Int J Radiat Oncol Biol Phys 76 2010 14 22
14. R.K. Valicenti, K. Winter, and J.D. Cox RTOG 94-06: is the addition of neoadjuvant hormonal therapy to dose-escalated 3D conformal radiation therapy for prostate cancer associated with treatment toxicity? Int J Radiat Oncol Biol Phys 57 2003 614 620 (Pubitemid 37194286)
15. S.L. Tucker, L. Dong, and W.R. Bosch Late rectal toxicity on RTOG 94-06: analysis using a mixture Lyman model Int J Radiat Oncol Biol Phys 78 2010 1253 1260
16. J.T. Lyman Complication probability as assessed from dose-volume histograms Radiat Res Suppl 8 1985 S13 S19
17. G.J. Kutcher, and C. Burman Calculation of complication probability factors for non-uniform normal tissue irradiation: the effective volume method Int J Radiat Oncol Biol Phys 16 1989 1623 1630 (Pubitemid 19154353)
18. S.T.H. Peeters, M.S. Hoogeman, W.D. Heemsbergen, A.A.M. Hart, P.C.M. Koper, and J.V. Lebesque Rectal bleeding, fecal incontinence, and high stool frequency after conformal radiotherapy for prostate cancer: normal tissue complication probability modeling Int J Radiat Oncol Biol Phys 66 2006 11 19 (Pubitemid 44175644)
19. S.L. Tucker, H.D. Thames, and J.M. Michalski Estimation of αβ for late rectal toxicity based on RTOG 94-06 Int J Radiat Oncol Biol Phys 81 2011 600 605
20. S.L. Tucker, L. Dong, J.M. Michalski, W.R. Bosch, K. Winter, J.D. Cox, J.A. Purdy, and R. Mohan Do intermediate radiation doses contribute to late rectal toxicity? An analysis of data from radiation therapy oncology group protocol 94-06 Int J Radiat Oncol Biol Phys 2012 10.1016/j.ijrobp.2011.11.073